Lifetime QALE, cost, and cost-effectiveness estimates associated with Standard and Innovative TKA.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Lifetime_QALE_cost_and_cost_effectiveness_estimates_associated_with_Standard_and_Innovative_TKA_/697799
下载链接
链接失效反馈官方服务：
资源简介：
*No obesity or comorbidity at baseline.†Baseline obesity, cardiovascular disease, and non-OA musculoskeletal disease.‡ICER = incremental cost-effectiveness ratio in 2010 US$ per quality-adjusted life-year (QALY) gained, compared with standard TKA. “Cost saving” indicates greater QALYs achieved at a lower cost compared to standard TKA.
创建时间：
2015-12-02
